PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some big stocks recording losses in today’s session.

Akero Therapeutics, Inc. AKRO shares dipped 63.9% to $17.52 after the company reported a 36-week analysis of its Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate, efruxifermin.
89bio, Inc. ETNB tumbled 37.7% to $9.68.
Ventyx Biosciences, Inc. VTYX fell 22.1% to $23.38 after the company announced results from the Phase 2 trial of VTX002 in patients with moderate-to-severely active ulcerative colitis.
John Wiley & Sons, Inc. WLY shares dipped 10.4% to $31.02. Wiley reported the departure of Brian Napack as President and CEO, and the appointment of Matthew Kissner as Interim CEO, effective immediately.
Groupon, Inc. GRPN declined 9% to $13.83.
Uranium Royalty Corp. UROY fell 7.1% to $2.91.
WK Kellogg Co KLG fell 6.6% to $10.69.
Neumora Therapeutics, Inc. NMRA declined 6% to $11.23. Neumora reported the appointment of Robert Lenz, M.D., Ph.D., as executive vice president, head of research and development.
SunCar Technology Group Inc. SDA fell 5.7% to $9.56.
Genelux Corporation GNLX fell 5.7% to $22.43.
PagerDuty, Inc. PD shares fell 3.7% to $21.03 after the company announced a proposed private placement of $350 million of convertible senior notes.